Doctor OctoPlus
This article was originally published in The Gray Sheet
Executive Summary
SurModics obtains an option to acquire an exclusive license from OctoPlus for the OctoDEX and PolyActive biodegradable drug delivery polymers. SurModics plans to use the technology, which is suitable for use with proteins and large molecule therapeutic agents, as biodegradable coatings or as fully degradable products. PolyActive is used for controlled release of proteins and hydrophobic small molecule drugs. OctoDEX is based on "cross-linked dextran microspheres" used for timed release of proteins and large particles, such as liposomes and antigens. Both polymers are undergoing preclinical and clinical evaluation for use as pharmaceutical formulations...